Filing Flows › Teva Pharmaceutical Industries (TEVA) › Who owns the stock
Who owns Teva Pharmaceutical Industries (TEVA) stock
0 funds reported Teva Pharmaceutical Industries (TEVA) shares in their latest 13F filings. Members of Congress and other officials disclosed 1 trade (1 buys, 0 sales).
Trades by Congress and other officials
| Date | Who | Trade | Amount |
|---|---|---|---|
| 2026-03-30 | Alan Armstrong | purchase | $1K–$15K |
Teva Pharmaceutical Industries' latest quarter
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Questions
Has Congress traded TEVA stock?
Officials disclosed 1 trade on file: 1 buys and 0 sales. The latest: Alan Armstrong, purchase on 2026-03-30.
What is the short interest in TEVA?
28,070,513 shares were sold short at the 2026-10-15 settlement, -5.96% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.